In this latest issue of my weekly podcast, we talk about the hope for a vaccine. On Monday, markets rose with the news of positive results from the latest Moderna study. While the study was technicality a phase 1 trial, testing if the drug is safe for human consumption, they also did preliminary tests on its effectiveness. Of the 8 patients tested, all showed levels of antibodies equal to or above those of someone who has recovered from COVID19. While RNA vaccines are extremely promising, the...